UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

Leukemia, 2010-03, Vol.24 (3), p.512-520

2010

Volltextzugriff (PDF)

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

Leukemia, 2013-01, Vol.27 (1), p.170-182

2013

Volltextzugriff (PDF)

Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis

Leukemia, 2010-01, Vol.24 (1), p.133-140

2010

Volltextzugriff (PDF)

Presence of pores and hydrogel composition influence tensile properties of scaffolds fabricated from well-defined sphere templates

Journal of biomedical materials research. Part B, Applied biomaterials, 2011-02, Vol.96B (2), p.294-302

2011

Volltextzugriff (PDF)

BAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC)

Annals of oncology, 2018-10, Vol.29, p.viii331-viii331

2018

Volltextzugriff (PDF)

Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering

Acta biomaterialia, 2009-10, Vol.5 (8), p.2929-2938

2009

Volltextzugriff (PDF)

Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Annals of oncology, 2019-10, Vol.30, p.v485-v486

2019

Volltextzugriff (PDF)

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL

Leukemia, 2011-09, Vol.25 (9), p.1459-1466

2011

Volltextzugriff (PDF)

MEDIOLA: A phase I/II trial of olaparib (PARP inhibitor) in combination with durvalumab (anti-PD-L1 antibody) in pts with advanced solid tumours - new ovarian cancer cohorts

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii147

2018

Volltextzugriff (PDF)

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

Leukemia, 2014-11, Vol.28 (11), p.2251-2254

2014

Volltextzugriff (PDF)

LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells

Leukemia, 2010-09, Vol.24 (9), p.1580-1587

2010

Volltextzugriff (PDF)

The Construct Validity of Student Engagement: A Confirmatory Factor Analysis Approach

Research in higher education, 2009-06, Vol.50 (4), p.315-332

2009

Volltextzugriff (PDF)

Increased impulsive choice for saccharin during PCP withdrawal in female monkeys: influence of menstrual cycle phase

Psychopharmacology, 2013-06, Vol.227 (3), p.413-424

2013

Volltextzugriff (PDF)

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Nature communications, 2018-02, Vol.9 (1), p.697-22, Article 697

2018

Volltextzugriff (PDF)

P2.01-18 ORION: Durvalumab+Olaparib Versus Durvalumab Alone as Maintenance Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S645-S646

2019

Volltextzugriff (PDF)

929TiPBAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Distortion or Clarification: Defining Highly Qualified Teachers and the Relationship between Certification and Achievement

Education policy analysis archives, 2010-11, Vol.18 (27), p.27

2010

Volltextzugriff (PDF)

THE IMPACT OF ON-CAMPUS STUDENT GROWTH ON FIRST-YEAR STUDENT ENGAGEMENT AND SUCCESS

Research in higher education, 2007-12, Vol.48 (8), p.941-966

2007

Volltextzugriff (PDF)

5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S250-S250

2011

Volltextzugriff (PDF)

1190PD - Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Annals of oncology, 2019-10, Vol.30, p.v485-v486

2019

Volltextzugriff (PDF)

Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

Annals of oncology, 2016-10, Vol.27, p.vi361-vi361

2016

Volltextzugriff (PDF)

Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

Annals of oncology, 2019-10, Vol.30, p.v477

2019

Volltextzugriff (PDF)

1191O - Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

Annals of oncology, 2019-10, Vol.30, p.v477-v477

2019

Volltextzugriff (PDF)

A novel X chromosome–linked genetic cause of recurrent spontaneous abortion

American journal of obstetrics and gynecology, 2001-09, Vol.185 (3), p.563-568

2001

Volltextzugriff (PDF)

Scanning electrochemical microscopy measurements of photopolymerized poly(ethylene glycol) hydrogels

Polymer (Guilford), 2010-10, Vol.51 (23), p.5456-5461

2010

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Englisch
(135)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Humans
(55)
Life Sciences & Biomedicine
(55)
Male
(36)
Female
(35)
Biological And Medical Sciences
(34)
Medical Sciences
(31)
Hematology
(24)
Adult
(19)
Middle Aged
(18)
Oncology
(18)
Aged
(15)
Hematologic And Hematopoietic Diseases
(15)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Chronic Lymphocytic Leukemia
(11)
Leukemia
(10)
B-Lymphocytes - Pathology
(9)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(9)
Risk Factors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis

Presence of pores and hydrogel composition influence tensile properties of scaffolds fabricated from well-defined sphere templates

BAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC)

Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering

Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL

MEDIOLA: A phase I/II trial of olaparib (PARP inhibitor) in combination with durvalumab (anti-PD-L1 antibody) in pts with advanced solid tumours - new ovarian cancer cohorts

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells

The Construct Validity of Student Engagement: A Confirmatory Factor Analysis Approach

Increased impulsive choice for saccharin during PCP withdrawal in female monkeys: influence of menstrual cycle phase

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

P2.01-18 ORION: Durvalumab+Olaparib Versus Durvalumab Alone as Maintenance Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

929TiPBAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC)

Distortion or Clarification: Defining Highly Qualified Teachers and the Relationship between Certification and Achievement

THE IMPACT OF ON-CAMPUS STUDENT GROWTH ON FIRST-YEAR STUDENT ENGAGEMENT AND SUCCESS

5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia

1190PD - Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

1191O - Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

A novel X chromosome–linked genetic cause of recurrent spontaneous abortion

Scanning electrochemical microscopy measurements of photopolymerized poly(ethylene glycol) hydrogels

Suchergebnisse filtern